John Overdeck’s BlackRock Health Sciences Trust BME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-46,481
Closed -$1.91M 4598
2025
Q4
$1.91M Hold
46,481
﹤0.01% 2467
2025
Q3
$1.73M Buy
46,481
+11,371
+32% +$413K ﹤0.01% 2223
2025
Q2
$1.28M Buy
+35,110
New +$1.27M ﹤0.01% 2109
2024
Q4
Sell
-6,189
Closed -$260K 3224
2024
Q3
$260K Sell
6,189
-11,222
-64% -$466K ﹤0.01% 2732
2024
Q2
$711K Buy
+17,411
New +$693K ﹤0.01% 2184

Other funds holding BME

John Overdeck's BME Position: Q1 2026 in Review

John Overdeck sold out of BlackRock Health Sciences Trust (BME) in Q1 2026, closing a stake of 46,481 shares — an estimated $1.91M sold.

John Overdeck first reported a position in BME in Q2 2024 and held it in 5 quarters. The position peaked at $1.91M in Q4 2025. 76 funds tracked by Wall St. Rank hold BME as of Q1 2026.

  • John Overdeck reported no remaining BlackRock Health Sciences Trust position as of Q1 2026 after selling out during the quarter.
  • John Overdeck sold 46,481 BlackRock Health Sciences Trust shares in Q1 2026, an estimated $1.91M.
  • John Overdeck first reported a position in BlackRock Health Sciences Trust in Q2 2024 and held it in 5 quarters.
  • John Overdeck's BlackRock Health Sciences Trust position peaked at $1.91M in Q4 2025.
  • 76 funds tracked by Wall St. Rank held BlackRock Health Sciences Trust as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.